1260 – 1188 West Georgia Street,
Member Sector: Biopharmaceuticals
Neurodyn Inc, a Canadian biotechnology company, is developing and marketing early stage, pre-clinical, diagnostic and theraputic products to treat neurodegeneration. Neurodyn’s patented pending animal model recreates neurodegeneration that occured in a group of human patients and of pre-clinical stages of neurodegeneration. Neurodyn has been awarded over $5.2 million in financial grants to support the development of its model.